Holdings
Vivo Capital, LLC
As of Sep 30, 2026, Vivo Capital, LLC reported 47 positions worth US$829M. Largest: Praxis Precision Medicines, Inc., Trevi Therapeutics, Inc. and Erasca, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Praxis Precision Medicines, Inc. | 271K | US$79M | no change | Sep 30, 2026 |
| Trevi Therapeutics, Inc. | 4.23M | US$60.6M | −865K | Sep 30, 2026 |
| Erasca, Inc. | 4.02M | US$58.9M | −107K | Sep 30, 2026 |
| ArriVent BioPharma, Inc. | 1.79M | US$54.1M | +105K | Sep 30, 2026 |
| Abivax SA | 415K | US$41.1M | no change | Sep 30, 2026 |
| Aclaris Therapeutics, Inc. | 6.69M | US$35.2M | no change | Sep 30, 2026 |
| Alto Neuroscience, Inc. | 1.36M | US$34.7M | +151K | Sep 30, 2026 |
| Tango Therapeutics, Inc. | 1.38M | US$34.4M | no change | Sep 30, 2026 |
| Corvus Pharmaceuticals, Inc. | 2.81M | US$32.3M | no change | Sep 30, 2026 |
| LB Pharmaceuticals Inc | 800K | US$30.7M | no change | Sep 30, 2026 |